NCT02038829 - A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions

COPD

Interventions

DRUG

Placebo

DRUG

SUN101 3 mcg

SUN-101 3 mcg bid

DRUG

SUN-101 6.25 mcg

SUN-101 6.25 mcg bid

DRUG

SUN-101 12.5 mcg

SUN-101 12.5 mcg bid

DRUG

SUN-101 50 mcg

SUN-101 50 mcg bid

DRUG

Aclidinium

Aclidinium 400 mcg bid

Trial Locations (10)

27607

North Carolina Clinical Research, Raleigh

28207

American Health Research, Inc., Charlotte

29303

S. Carolina, Spartanburg

Spartanburg Medical Research, Spartanburg

29379

CU Pharmaceutical Research, Union

29615

Greenville Pharmaceutical Research, Inc., Greenville

Upstate Pharmaceutical Research, Greenville

29640

Palmetto Medical Research Associates, LLC, Easley

33765

Clinical Research of West Florida, Inc., Clearwater

97504

Clinical Research Institute of Southern Oregon, PC, Medford

All Listed Sponsors

lead

Sunovion Respiratory Development Inc.

INDUSTRY